ASTM F 2901 : 2026

1.1Medical devices may cause adverse effects on the structure and/or function of the nervous system. In this guide, these adverse effects are defined as neurotoxicity. This guide provides background information and recommendations on methods for neurotoxicity testing and other assessments that are pertinent for devices contacting central and/or peripheral nervous system tissue or cerebrospinal fluid (CSF). This guide does not describe all relevant biocompatibility endpoint assessments based on the duration and nature of tissue contact of the device and should be used in conjunction with Practice F748.

1.2This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.3This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.